Compute Health Acquisition Corp Compute Health Acquisition Corp (CPUH-WT) operates as a blank check company, or special purpose acquisition company, focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting healthcare companies leveraging computational power such as those in medical devices, imaging, and robotics; its core offerings include public units, redeemable Class A common stock, and public warrants exercisable into Class A shares at a specified price. Incorporated in 2020 as a Delaware corporation and headquartered at 1105 North Market Street, Suite 1300, Wilmington, Delaware, the company raised $750 million in its February 2021 initial public offering underwritten by Goldman Sachs. In July 2023, Compute Health Acquisition Corp stockholders approved its business combination with Allurion Technologies, Inc., a weight loss platform provider featuring the swallowable Allurion Gastric Balloon, Virtual Care Suite, and connected devices; the merger closed shortly thereafter with Compute Health merging into Allurion, resulting in Allurion Technologies Holdings, Inc. trading on the NYSE under ALUR while CPUH-WT warrants were assumed and converted into Allurion public warrants, reflecting the company's completed strategic shift to support obesity treatment innovation through computational healthcare advancements.